Remove 2023 Remove Life Science Remove mHealth Remove Public Health
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. 2 Digital health is a large (+$900bn by 2032) and growing (13.6% Accessed November 2023. Accessed November 2023.

article thumbnail

The Biggest Growth Opportunities in Healthcare

Henry Kotula

Telemedicine will move into the public health space as well, with countries like Singapore is testing the platforms in a regulatory sandbox. from 2017 to 2023. Despite the promises with novel cell and gene therapies such as CRISPR /Cas9, questions around ethical application challenge its future potential.